AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2005
Jan 3, 2005
35134_dirs_2005-01-03_1f400456-c492-423f-bc8a-7aa969b81658.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: CROFF ENTERPRISES INC (coff)
CIK: 0000025743
Period of Report: 2004-12-31
Reporting Person: MANDEL RICHARD H JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-03-22 | Croff Enterprises, Inc. Common Stock | P | 1400 | $0.7 | Acquired | 15100 | Direct |
| 2004-05-10 | Croff Enterprises, Inc. Common Stock | P | 1600 | $0.7 | Acquired | 15100 | Direct |
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 16